Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement

Summary This consensus statement presents the conclusions of a group of academic and industrial experts who met in London in September, 2006, to consider the issues associated with the treatment of hospital infections caused by Gram-negative bacteria. The group discussed the severe clinical problems...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet infectious diseases 2008-02, Vol.8 (2), p.133-139
Main Authors: Chopra, Ian, Prof, Schofield, Christopher, Prof, Everett, Martin, PhD, O'Neill, Alex, PhD, Miller, Keith, PhD, Wilcox, Mark, Prof, Frère, Jean-Marie, Prof, Dawson, Mike, PhD, Czaplewski, Lloyd, PhD, Urleb, Uros, PhD, Courvalin, Patrice, Prof
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Antibacterial agents
Antibiotic resistance
Bacteria
Biological and medical sciences
Cross Infection - drug therapy
Drug Design
Drug Resistance, Bacterial
General aspects
Gram-Negative Bacteria - drug effects
Gram-Negative Bacterial Infections - drug therapy
Gram-Negative Bacterial Infections - microbiology
Human infectious diseases. Experimental studies and models
Humans
Infectious Disease
Infectious diseases
Medical sciences
Pharmaceutical industry
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c527t-877f38698832b2a401551556f0b2c36479872f75077c9401b5929c1e06b818e33
cites cdi_FETCH-LOGICAL-c527t-877f38698832b2a401551556f0b2c36479872f75077c9401b5929c1e06b818e33
container_end_page 139
container_issue 2
container_start_page 133
container_title The Lancet infectious diseases
container_volume 8
creator Chopra, Ian, Prof
Schofield, Christopher, Prof
Everett, Martin, PhD
O'Neill, Alex, PhD
Miller, Keith, PhD
Wilcox, Mark, Prof
Frère, Jean-Marie, Prof
Dawson, Mike, PhD
Czaplewski, Lloyd, PhD
Urleb, Uros, PhD
Courvalin, Patrice, Prof
description Summary This consensus statement presents the conclusions of a group of academic and industrial experts who met in London in September, 2006, to consider the issues associated with the treatment of hospital infections caused by Gram-negative bacteria. The group discussed the severe clinical problems arising from the emergence of antibiotic resistance in these bacteria and the lack of new antibacterial agents to challenge the threat. The discovery of new drugs active against hospital-acquired Gram-negative bacteria is essential to prevent a future medical and social catastrophe. An important strategy to promote drug discovery will be the development of focused cooperations between academic institutions and small pharmaceutical companies.
doi_str_mv 10.1016/S1473-3099(08)70018-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70235714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1473309908700185</els_id><sourcerecordid>70235714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-877f38698832b2a401551556f0b2c36479872f75077c9401b5929c1e06b818e33</originalsourceid><addsrcrecordid>eNqFkV1rFTEQhhdRbK3-BGURFHuxms9N4oUixbZCwQvrdcjmzNrU3WybyRbOvzd79mChN4VAwuSZdz7eqnpNyUdKaPvpFxWKN5wY84HoY0UI1Y18Uh2WsGiEkOrp7r0iB9ULxOvCKErE8-qAasYYbcVh1V8mcHmEmOupr6_ADfmq8S5B4xAnH1yGTR1iDz6HKWLt3Ywl0m3rs-TGJsIfl8Md1J3zGVJwn2tX-wJCxBlrzCV_EX9ZPevdgPBqfx9Vv0-_X56cNxc_z36cfLtovGQqN1qpnuvWaM1Zx5wgVMpy2p50zPNWKKMV65UkSnlTfjtpmPEUSNtpqoHzo-r9qnuTptsZMNsxoIdhcBGmGa0ijEtFRQHfPgCvpznF0ptlS1VOpC6QXCGfJsQEvb1JYXRpaymxiwt254JdVmyJtjsXrCx5b_biczfC5j5rv_YCvNsDDr0b-uSiD3jPGaO5MAv3deWg7OwuQLLoA0QPm5CKI3YzhUdb-fJAwQ8hhlL0L2wB_w9NLTJLVpFFg-idguT_AKAhtuM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201553058</pqid></control><display><type>article</type><title>Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement</title><source>ScienceDirect Freedom Collection</source><creator>Chopra, Ian, Prof ; Schofield, Christopher, Prof ; Everett, Martin, PhD ; O'Neill, Alex, PhD ; Miller, Keith, PhD ; Wilcox, Mark, Prof ; Frère, Jean-Marie, Prof ; Dawson, Mike, PhD ; Czaplewski, Lloyd, PhD ; Urleb, Uros, PhD ; Courvalin, Patrice, Prof</creator><creatorcontrib>Chopra, Ian, Prof ; Schofield, Christopher, Prof ; Everett, Martin, PhD ; O'Neill, Alex, PhD ; Miller, Keith, PhD ; Wilcox, Mark, Prof ; Frère, Jean-Marie, Prof ; Dawson, Mike, PhD ; Czaplewski, Lloyd, PhD ; Urleb, Uros, PhD ; Courvalin, Patrice, Prof</creatorcontrib><description>Summary This consensus statement presents the conclusions of a group of academic and industrial experts who met in London in September, 2006, to consider the issues associated with the treatment of hospital infections caused by Gram-negative bacteria. The group discussed the severe clinical problems arising from the emergence of antibiotic resistance in these bacteria and the lack of new antibacterial agents to challenge the threat. The discovery of new drugs active against hospital-acquired Gram-negative bacteria is essential to prevent a future medical and social catastrophe. An important strategy to promote drug discovery will be the development of focused cooperations between academic institutions and small pharmaceutical companies.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(08)70018-5</identifier><identifier>PMID: 18222164</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibacterial agents ; Antibiotic resistance ; Bacteria ; Biological and medical sciences ; Cross Infection - drug therapy ; Drug Design ; Drug Resistance, Bacterial ; General aspects ; Gram-Negative Bacteria - drug effects ; Gram-Negative Bacterial Infections - drug therapy ; Gram-Negative Bacterial Infections - microbiology ; Human infectious diseases. Experimental studies and models ; Humans ; Infectious Disease ; Infectious diseases ; Medical sciences ; Pharmaceutical industry</subject><ispartof>The Lancet infectious diseases, 2008-02, Vol.8 (2), p.133-139</ispartof><rights>Elsevier Ltd</rights><rights>2008 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Elsevier Limited Feb 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-877f38698832b2a401551556f0b2c36479872f75077c9401b5929c1e06b818e33</citedby><cites>FETCH-LOGICAL-c527t-877f38698832b2a401551556f0b2c36479872f75077c9401b5929c1e06b818e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19983494$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18222164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chopra, Ian, Prof</creatorcontrib><creatorcontrib>Schofield, Christopher, Prof</creatorcontrib><creatorcontrib>Everett, Martin, PhD</creatorcontrib><creatorcontrib>O'Neill, Alex, PhD</creatorcontrib><creatorcontrib>Miller, Keith, PhD</creatorcontrib><creatorcontrib>Wilcox, Mark, Prof</creatorcontrib><creatorcontrib>Frère, Jean-Marie, Prof</creatorcontrib><creatorcontrib>Dawson, Mike, PhD</creatorcontrib><creatorcontrib>Czaplewski, Lloyd, PhD</creatorcontrib><creatorcontrib>Urleb, Uros, PhD</creatorcontrib><creatorcontrib>Courvalin, Patrice, Prof</creatorcontrib><title>Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Summary This consensus statement presents the conclusions of a group of academic and industrial experts who met in London in September, 2006, to consider the issues associated with the treatment of hospital infections caused by Gram-negative bacteria. The group discussed the severe clinical problems arising from the emergence of antibiotic resistance in these bacteria and the lack of new antibacterial agents to challenge the threat. The discovery of new drugs active against hospital-acquired Gram-negative bacteria is essential to prevent a future medical and social catastrophe. An important strategy to promote drug discovery will be the development of focused cooperations between academic institutions and small pharmaceutical companies.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotic resistance</subject><subject>Bacteria</subject><subject>Biological and medical sciences</subject><subject>Cross Infection - drug therapy</subject><subject>Drug Design</subject><subject>Drug Resistance, Bacterial</subject><subject>General aspects</subject><subject>Gram-Negative Bacteria - drug effects</subject><subject>Gram-Negative Bacterial Infections - drug therapy</subject><subject>Gram-Negative Bacterial Infections - microbiology</subject><subject>Human infectious diseases. Experimental studies and models</subject><subject>Humans</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Pharmaceutical industry</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFkV1rFTEQhhdRbK3-BGURFHuxms9N4oUixbZCwQvrdcjmzNrU3WybyRbOvzd79mChN4VAwuSZdz7eqnpNyUdKaPvpFxWKN5wY84HoY0UI1Y18Uh2WsGiEkOrp7r0iB9ULxOvCKErE8-qAasYYbcVh1V8mcHmEmOupr6_ADfmq8S5B4xAnH1yGTR1iDz6HKWLt3Ywl0m3rs-TGJsIfl8Md1J3zGVJwn2tX-wJCxBlrzCV_EX9ZPevdgPBqfx9Vv0-_X56cNxc_z36cfLtovGQqN1qpnuvWaM1Zx5wgVMpy2p50zPNWKKMV65UkSnlTfjtpmPEUSNtpqoHzo-r9qnuTptsZMNsxoIdhcBGmGa0ijEtFRQHfPgCvpznF0ptlS1VOpC6QXCGfJsQEvb1JYXRpaymxiwt254JdVmyJtjsXrCx5b_biczfC5j5rv_YCvNsDDr0b-uSiD3jPGaO5MAv3deWg7OwuQLLoA0QPm5CKI3YzhUdb-fJAwQ8hhlL0L2wB_w9NLTJLVpFFg-idguT_AKAhtuM</recordid><startdate>20080201</startdate><enddate>20080201</enddate><creator>Chopra, Ian, Prof</creator><creator>Schofield, Christopher, Prof</creator><creator>Everett, Martin, PhD</creator><creator>O'Neill, Alex, PhD</creator><creator>Miller, Keith, PhD</creator><creator>Wilcox, Mark, Prof</creator><creator>Frère, Jean-Marie, Prof</creator><creator>Dawson, Mike, PhD</creator><creator>Czaplewski, Lloyd, PhD</creator><creator>Urleb, Uros, PhD</creator><creator>Courvalin, Patrice, Prof</creator><general>Elsevier Ltd</general><general>Lancet Publishing Group</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20080201</creationdate><title>Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement</title><author>Chopra, Ian, Prof ; Schofield, Christopher, Prof ; Everett, Martin, PhD ; O'Neill, Alex, PhD ; Miller, Keith, PhD ; Wilcox, Mark, Prof ; Frère, Jean-Marie, Prof ; Dawson, Mike, PhD ; Czaplewski, Lloyd, PhD ; Urleb, Uros, PhD ; Courvalin, Patrice, Prof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-877f38698832b2a401551556f0b2c36479872f75077c9401b5929c1e06b818e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotic resistance</topic><topic>Bacteria</topic><topic>Biological and medical sciences</topic><topic>Cross Infection - drug therapy</topic><topic>Drug Design</topic><topic>Drug Resistance, Bacterial</topic><topic>General aspects</topic><topic>Gram-Negative Bacteria - drug effects</topic><topic>Gram-Negative Bacterial Infections - drug therapy</topic><topic>Gram-Negative Bacterial Infections - microbiology</topic><topic>Human infectious diseases. Experimental studies and models</topic><topic>Humans</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Pharmaceutical industry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chopra, Ian, Prof</creatorcontrib><creatorcontrib>Schofield, Christopher, Prof</creatorcontrib><creatorcontrib>Everett, Martin, PhD</creatorcontrib><creatorcontrib>O'Neill, Alex, PhD</creatorcontrib><creatorcontrib>Miller, Keith, PhD</creatorcontrib><creatorcontrib>Wilcox, Mark, Prof</creatorcontrib><creatorcontrib>Frère, Jean-Marie, Prof</creatorcontrib><creatorcontrib>Dawson, Mike, PhD</creatorcontrib><creatorcontrib>Czaplewski, Lloyd, PhD</creatorcontrib><creatorcontrib>Urleb, Uros, PhD</creatorcontrib><creatorcontrib>Courvalin, Patrice, Prof</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chopra, Ian, Prof</au><au>Schofield, Christopher, Prof</au><au>Everett, Martin, PhD</au><au>O'Neill, Alex, PhD</au><au>Miller, Keith, PhD</au><au>Wilcox, Mark, Prof</au><au>Frère, Jean-Marie, Prof</au><au>Dawson, Mike, PhD</au><au>Czaplewski, Lloyd, PhD</au><au>Urleb, Uros, PhD</au><au>Courvalin, Patrice, Prof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2008-02-01</date><risdate>2008</risdate><volume>8</volume><issue>2</issue><spage>133</spage><epage>139</epage><pages>133-139</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>Summary This consensus statement presents the conclusions of a group of academic and industrial experts who met in London in September, 2006, to consider the issues associated with the treatment of hospital infections caused by Gram-negative bacteria. The group discussed the severe clinical problems arising from the emergence of antibiotic resistance in these bacteria and the lack of new antibacterial agents to challenge the threat. The discovery of new drugs active against hospital-acquired Gram-negative bacteria is essential to prevent a future medical and social catastrophe. An important strategy to promote drug discovery will be the development of focused cooperations between academic institutions and small pharmaceutical companies.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>18222164</pmid><doi>10.1016/S1473-3099(08)70018-5</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1473-3099
ispartof The Lancet infectious diseases, 2008-02, Vol.8 (2), p.133-139
issn 1473-3099
1474-4457
language eng
recordid cdi_proquest_miscellaneous_70235714
source ScienceDirect Freedom Collection
subjects Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Antibacterial agents
Antibiotic resistance
Bacteria
Biological and medical sciences
Cross Infection - drug therapy
Drug Design
Drug Resistance, Bacterial
General aspects
Gram-Negative Bacteria - drug effects
Gram-Negative Bacterial Infections - drug therapy
Gram-Negative Bacterial Infections - microbiology
Human infectious diseases. Experimental studies and models
Humans
Infectious Disease
Infectious diseases
Medical sciences
Pharmaceutical industry
title Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T16%3A53%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20health-care-associated%20infections%20caused%20by%20Gram-negative%20bacteria:%20a%20consensus%20statement&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Chopra,%20Ian,%20Prof&rft.date=2008-02-01&rft.volume=8&rft.issue=2&rft.spage=133&rft.epage=139&rft.pages=133-139&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(08)70018-5&rft_dat=%3Cproquest_cross%3E70235714%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c527t-877f38698832b2a401551556f0b2c36479872f75077c9401b5929c1e06b818e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=201553058&rft_id=info:pmid/18222164&rfr_iscdi=true